Recent advances in pulmonary arterial hypertension [version 1; referees: 2 approved]
Pulmonary arterial hypertension (PAH) is a rare disorder with a high mortality rate. Treatment options have improved in the last 20 years, but patients still die prematurely of right heart failure. Though rare, it is heterogeneous at the genetic and molecular level, and understanding and exploiting...
Main Authors: | Martin R. Wilkins, Jurjan Aman, Lars Harbaum, Anna Ulrich, John Wharton, Christopher J. Rhodes |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-07-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-1128/v1 |
Similar Items
-
Recent advances in the management of pulmonary arterial hypertension [version 1; referees: 2 approved]
by: Halley Tsai, et al.
Published: (2016-11-01) -
Recent advances in understanding idiopathic pulmonary fibrosis [version 1; referees: 2 approved]
by: Cécile Daccord, et al.
Published: (2016-05-01) -
Recent advances in managing idiopathic pulmonary fibrosis [version 1; referees: 4 approved]
by: Chiara Scelfo, et al.
Published: (2017-11-01) -
Recent advances in dermoscopy [version 1; referees: 2 approved]
by: Teresa Russo, et al.
Published: (2016-02-01) -
Recent advances in colonoscopy [version 1; referees: 2 approved]
by: Thomas J.W. Lee, et al.
Published: (2016-03-01)